Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,024.00
Bid: 12,024.00
Ask: 12,028.00
Change: 36.00 (0.30%)
Spread: 4.00 (0.033%)
Open: 12,254.00
High: 12,256.00
Low: 12,018.00
Prev. Close: 11,988.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Weak Pound Boosts FTSE 100; Countrywide Surges 18%

Mon, 07th Dec 2020 08:58

(Alliance News) - Stock prices in London opened mixed on Monday with the internationally exposed FTSE 100 benefiting from weakness in the pound.

M&A news was providing investors with added interest Monday morning, with Countrywide and Elementis, among others, receiving takeover offers.

UK Prime Minister Boris Johnson and European Commission President Ursula von der Leyen will assess whether a post-Brexit trade deal can be salvaged following a weekend of tense negotiations.

The two leaders will speak on Monday evening - their second call in a little over 48 hours - after their top negotiators spent Sunday locked in detailed talks.

David Frost and his EU counterpart Michel Barnier were ordered back to the negotiating table in a final push to see if they could break the stalemate.

However Irish premier Micheal Martin, who has been closely following the talks process, warned that they remained on a "knife-edge". Martin said there appeared to be a "very challenging issue" still to be resolved over the so-called "level playing field" rules on fair competition.

All eyes are on an EU summit on Thursday, with the prospect that any deal - or the failure to find one – will be put to the bloc's 27 leaders at that time. A source close to the talks said the situation was "very difficult" and that negotiations were in their "last useful days".

Without a deal, tariffs would be levied on the huge volumes of trade passing between the UK and the European continent, through the Channel tunnel and by ship, starting on January 1.

The FTSE 100 index was up 10.19 points, or 0.1%, at 6,560.42 early Monday. The mid-cap FTSE 250 index was down 97.12 points, or 0.5%, at 20,085.57. The AIM All-Share index was up 0.4% at 1,072.74.

The Cboe UK 100 index was up 0.1% at 653.35. The Cboe 250 was down 0.5% at 17402.54. The Cboe Small Companies down 0.1% at 11,712.00.

In mainland Europe, the CAC 40 in Paris was down 0.7% while the DAX 30 in Frankfurt was down 0.5% early Monday.

The pound was quoted at USD1.3297 early Monday, sharply lower from USD1.3470 at the London equities close Friday.

At the end of last week, sterling breached the USD1.35 mark, reaching its strongest level since May 2018 on hopes of a Brexit trade agreement. However, cable fell sharply on nervousness over whether a deal will be agreed.

"The Brexit-weakened pound is giving the FTSE a leg up in addition to optimism surrounding the roll out of Pfizer's Covid vaccine which starts this week," said City Index analyst Fiona Cincotta. "The softer tone surrounding the pound is beneficial to multinationals on the FTSE 100 which earn abroad. This accounts for over 70% of the index, boosting it higher."

In the FTSE 100, AstraZeneca was up 2.0% after Morgan Stanley raised the Anglo-Swedish drugmaker to Overweight from Equal Weight. Additionally, on Sunday, AstraZeneca reported ACE-LY-004 phase II trial results, showing efficacy and a steady safety profile for Calquence in mantle cell lymphoma.

At the other end of the large caps, HSBC was down 2.1% after Bank of America downgraded the China-focused lender to Underperform from Neutral.

Elsewhere in London, Countrywide was up 18% at 302.32 pence after the estate agent received an improved offer from peer Connells. Connells offered 325p per share in cash, saying it raised its offer by 30% following discussions with Countrywide's major shareholders.

In response, Countrywide said it will evaluate the merits of the Connells offer but urged shareholders to take no action in the meantime.

Elementis was down 2.1% at 124.10p after the speciality chemicals company said that it received a revised conditional proposal from Minerals Technologies late Friday for a possible cash offer for Elementis at 130 pence per share.

The board of Elementis rejected the offer, saying it was significantly short of a value that would merit engagement and access to the company's non-public information, despite the "continued opportunistic bidding tactics of Minerals Technologies".

The euro was priced at USD1.2111, down from USD1.2140. Against the Japanese yen, the dollar was trading at JPY104.19, flat from JPY104.20.

Brent oil was quoted at USD49.05 a barrel on Monday morning, flat from USD49.08 late Friday. Gold was trading at USD1,838.02 an ounce, up from USD1,832.24.

The Japanese Nikkei 225 index ended down 0.8%. In China, the Shanghai Composite closed down 0.8%, while the Hang Seng index in Hong Kong finished down 1.3%.

Investor sentiment in Asia was hurt by reports that the US is considering fresh sanctions on several Chinese officials over their roles in the disqualification of lawmakers in Hong Kong, as Donald Trump presses ahead with his fight against Beijing before leaving office.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.